Christopher Chapman
2023
In 2023, Christopher Chapman earned a total compensation of $2.9M as Former President, Chief Medical Officer at Akers Biosciences, a 1,002% increase compared to previous year.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Option Awards | $2,218,565 |
| Salary | $464,703 |
| Other | $1,058 |
| Total | $2,884,326 |
Chapman received $2.2M in option awards, accounting for 77% of the total pay in 2023.
Chapman also received $200K in bonus, $464.7K in salary and $1.1K in other compensation.
Rankings
In 2023, Christopher Chapman's compensation ranked 325th out of 2,978 executives tracked by ExecPay. In other words, Chapman earned more than 89.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 325 out of 2,978 | 89th |
Division Manufacturing | 181 out of 1,637 | 89th |
Major group Chemicals And Allied Products | 123 out of 906 | 86th |
Industry group Drugs | 120 out of 869 | 86th |
Industry In Vitro and In Vivo Diagnostic Substances | 1 out of 14 | 93rd |
Source: SEC filing on November 1, 2024.
Chapman's colleagues
We found three more compensation records of executives who worked with Christopher Chapman at Akers Biosciences in 2023.
News
Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
November 1, 2024
Akers Biosciences CSO Adam Kaplin's 2022 pay falls 93% to $354K
June 30, 2023
Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
October 26, 2022
Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
November 22, 2021